Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Molecular cytogenetic studies of a serially transplanted primary prostatic carcinoma xenograft (CWR22) and four relapsed tumors.

Kochera M, Depinet TW, Pretlow TP, Giaconia JM, Edgehouse NL, Pretlow TG, Schwartz S.

Prostate. 1999 Sep 15;41(1):7-11.

PMID:
10440870
2.

CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar.

Nagabhushan M, Miller CM, Pretlow TP, Giaconia JM, Edgehouse NL, Schwartz S, Kung HJ, de Vere White RW, Gumerlock PH, Resnick MI, Amini SB, Pretlow TG.

Cancer Res. 1996 Jul 1;56(13):3042-6.

3.

Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line.

Tepper CG, Boucher DL, Ryan PE, Ma AH, Xia L, Lee LF, Pretlow TG, Kung HJ.

Cancer Res. 2002 Nov 15;62(22):6606-14.

4.
5.

Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1.

Amler LC, Agus DB, LeDuc C, Sapinoso ML, Fox WD, Kern S, Lee D, Wang V, Leysens M, Higgins B, Martin J, Gerald W, Dracopoli N, Cordon-Cardo C, Scher HI, Hampton GM.

Cancer Res. 2000 Nov 1;60(21):6134-41.

6.

Stepwise genetic changes associated with progression of nontumorigenic HPV-18 immortalized human prostate cancer-derived cell line to a malignant phenotype.

Hukku B, Mally M, Cher ML, Peehl DM, Kung H, Rhim JS.

Cancer Genet Cytogenet. 2000 Jul 15;120(2):117-26.

PMID:
10942801
7.

Comparative genomic hybridization and molecular cytogenetic characterization of two prostate cancer xenografts.

Williams BJ, Jones E, Kozlowski JM, Vessella R, Brothman AR.

Genes Chromosomes Cancer. 1997 Apr;18(4):299-304.

PMID:
9087570
8.

CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma.

Wainstein MA, He F, Robinson D, Kung HJ, Schwartz S, Giaconia JM, Edgehouse NL, Pretlow TP, Bodner DR, Kursh ED, et al.

Cancer Res. 1994 Dec 1;54(23):6049-52.

9.

Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays.

Mousses S, Bubendorf L, Wagner U, Hostetter G, Kononen J, Cornelison R, Goldberger N, Elkahloun AG, Willi N, Koivisto P, Ferhle W, Raffeld M, Sauter G, Kallioniemi OP.

Cancer Res. 2002 Mar 1;62(5):1256-60.

10.

Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23.

Ellis WJ, Vessella RL, Buhler KR, Bladou F, True LD, Bigler SA, Curtis D, Lange PH.

Clin Cancer Res. 1996 Jun;2(6):1039-48.

12.

Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization.

Laitinen S, Karhu R, Sawyers CL, Vessella RL, Visakorpi T.

Genes Chromosomes Cancer. 2002 Sep;35(1):66-73.

PMID:
12203791
13.

Specific cytogenetic aberrations in two novel human prostatic cell lines immortalized by human papillomavirus type 18 DNA.

Weijerman PC, van Drunen E, König JJ, Teubel W, Romijn JC, Schröder FH, Hagemeijer A.

Cancer Genet Cytogenet. 1997 Dec;99(2):108-15.

PMID:
9398864
14.

Karyotypic similarity identified by multiplex-FISH relates four prostate adenocarcinoma cell lines: PC-3, PPC-1, ALVA-31, and ALVA-41.

Varella-Garcia M, Boomer T, Miller GJ.

Genes Chromosomes Cancer. 2001 Aug;31(4):303-15.

PMID:
11433521
15.

In vivo preservation of steroid specificity in CWR22 xenografts having a mutated androgen receptor.

Shao TC, Li H, Eid W, Ittmann M, Unni E, Cunningham GR.

Prostate. 2003 Sep 15;57(1):1-7.

PMID:
12886517
16.

Microarray analysis of prostate cancer progression to reduced androgen dependence: studies in unique models contrasts early and late molecular events.

Sirotnak FM, She Y, Khokhar NZ, Hayes P, Gerald W, Scher HI.

Mol Carcinog. 2004 Nov;41(3):150-63.

PMID:
15390081
17.

Identification of differentially expressed genes associated with androgen-independent growth of prostate cancer.

Mohler JL, Morris TL, Ford OH 3rd, Alvey RF, Sakamoto C, Gregory CW.

Prostate. 2002 Jun 1;51(4):247-55.

PMID:
11987153
18.

Flow cytometric and karyotypic analysis of a primary small cell carcinoma of the prostate: a xenografted cell line.

Pittman S, Russell PJ, Jelbart ME, Wass J, Raghavan D.

Cancer Genet Cytogenet. 1987 May;26(1):165-9.

PMID:
3030535

Supplemental Content

Support Center